Lexicon Pharmaceuticals (LXRX) Posts Q2 Loss of 6c/Share

July 30, 2013 6:44 AM

Lexicon Pharmaceuticals (NASDAQ: LXRX) reported Q1 EPS of ($0.06), $0.01 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found